AO
AOS.F Amdocs Limited
- Market cap
- EUR 4.05B
- P/E
- 10.1x
- P/B
- 1.32x
- ROE
- 14.5%
- Dividend yield
- 5.48%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Jun 2026.
Is AOS.F undervalued?
Graham numberAOS.F trades 23.2% below its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Amdocs Limited fundamental analysis
No fundamental analysis for Amdocs Limited yet.
Amdocs Limited stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Amdocs Limited
Amdocs Limited, through its subsidiaries, provides software and services to communications, entertainment, media, and other service providers worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud offering. The company also provides CES25, a telco-native, GenAI-led customer experience suite, spanning business, and operations and network domains that is embedded with AI and related tools. In addition, it offers GenAI agents, and wh…
Full company profileAmdocs Limited financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Amdocs Limited annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 3.72B | 3.87B | 3.97B | 4.09B | 4.17B | 4.29B | 4.58B | 4.89B | 5.00B | 4.53B | 4.67B |
| Gross Profit | 1.31B | 1.36B | 1.38B | 1.43B | 1.41B | 1.48B | 1.62B | 1.73B | 1.76B | 1.72B | 1.80B |
| Operating Income | 483M | 517M | 513M | 570M | 595M | 599M | 665M | 725M | 760M | 812M | 830M |
| EBITDA | - | 729M | 636M | 778M | 792M | 808M | 899M | 857M | 821M | 931M | 867M |
| Net Income | 409M | 437M | 354M | 479M | 498M | 688M | 550M | 541M | 493M | 565M | 477M |
| EPS | - | 3.03 | 2.53 | 3.56 | 3.78 | 5.44 | 4.51 | 4.61 | 4.37 | 5.21 | 4.57 |
| Balance Sheet | |||||||||||
| Total Assets | 5.33B | 5.28B | 5.35B | 5.29B | 6.34B | 6.51B | 6.39B | 6.43B | 6.39B | 6.25B | 6.42B |
| Total Liabilities | 1.88B | 1.71B | 1.86B | 1.75B | 2.68B | 2.88B | 2.83B | 2.86B | 2.89B | 2.78B | 3.09B |
| Shareholders' Equity | 3.45B | 3.57B | 3.45B | 3.50B | 3.62B | 3.59B | 3.52B | 3.52B | 3.46B | 3.43B | 3.29B |
| Cash & Short-term Investments | 769M | 650M | 419M | 472M | 983M | 709M | 573M | 520M | 346M | 325M | 206M |
| Cash Flow | |||||||||||
| Operating Cash Flow | 620M | 636M | 557M | 656M | 658M | 926M | 757M | 823M | 724M | 749M | 692M |
| Capital Expenditure | 130M | 133M | 232M | 138M | 206M | 211M | 228M | 124M | 105M | 104M | 105M |
| Free Cash Flow | - | 503M | 326M | 528M | 453M | 715M | 530M | 698M | 619M | 645M | 587M |
| Ratios | |||||||||||
| ROE | 11.9% | 12.2% | 10.3% | 13.7% | 13.7% | 19.2% | 15.6% | 15.3% | 14.3% | 16.5% | 14.5% |
| ROA | 7.7% | 8.3% | 6.6% | 9.1% | 7.9% | 10.6% | 8.6% | 8.4% | 7.7% | 9.0% | 7.4% |
| Net Profit Margin | 11.0% | 11.3% | 8.9% | 11.7% | 11.9% | 16.1% | 12.0% | 11.1% | 9.9% | 12.5% | 10.2% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Amdocs Limited dividends
- Dividend yield
- 5.48%
- Forward dividend
- 2.03 EUR
- Payout ratio
- 39.7%
- Ex-dividend date
- Jan 4, 2027
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | USD 224M | 2.07 | 39.7% |
| 2024 | USD 212M | 1.88 | 43.0% |
| 2023 | USD 199M | 1.70 | 36.9% |
| 2022 | USD 186M | 1.53 | 33.9% |
| 2021 | USD 177M | 1.40 | 25.8% |
| 2020 | USD 164M | 1.25 | 33.0% |
| 2019 | USD 148M | 1.10 | 30.8% |
| 2018 | USD 134M | 0.96 | 37.9% |
| 2017 | USD 122M | 0.84 | 27.8% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns Amdocs Limited
- Insiders 1.25%
- Institutions 98.75%
- Public & others 0.00%
- Shares outstanding 104M
- Free float 102M
Amdocs Limited company profile
- Company name
- Amdocs Limited
- Ticker
- AOS.F
- ISIN
- GB0022569080
- Exchange
- Frankfurt Exchange
- Sector
- Technology
- Industry
- Software
- Employees
- 26,969
- Fiscal year end
- September
- Address
- 625 Maryville Centre Drive, Saint Louis, MO, United States, 63141
- Phone
- 314 212 7000
- Website
- amdocs.com
About Amdocs Limited
Amdocs Limited, through its subsidiaries, provides software and services to communications, entertainment, media, and other service providers worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud offering. The company also provides CES25, a telco-native, GenAI-led customer experience suite, spanning business, and operations and network domains that is embedded with AI and related tools. In addition, it offers GenAI agents, and which include Customer Engagement Platform, a telecom-specific customer relationship management (CRM) solution; Amdocs Monetization Suite which enables customers to monetize their broad set of services and offerings; Amdocs Intelligent Networking Suite, a set of solutions that provide end-to-end service orchestration; Amdocs Charging; Amdocs eSIM Cloud that enables service providers to offer digital SIM (eSIM); Amdocs MarketONE, a based Software-as-a-Service (SaaS)-based platform that includes pre-integrated digital services, ranging from media, gaming, eLearning, sports and retail to security, and business services; and Amdocs connectX, a cloud-native telco-in-a-box software-as-a-service platform for digital telecom brands, as well as Amdocs CatalogONE that spans the entire CES25 suite and combines embedded business intelligence with telecom-specific GenAI agents. Further, the company provides consulting, experience design, data, cloud, network services, delivery, quality engineering, operations, systems integration, and content services to various platforms and technologies; maintenance, enhancement design and development, and operational support services; network deployment and optimization services; and managed services, including AI and related tools, predictive analytics, and robotic process automation, as well as quality engineering, mobile network, cloud, and professional services. Amdocs Limited was founded in 1982 and is headquartered in Saint Louis, Missouri.
Amdocs Limited management
8- Mr. Shimie HortigPresident, CEO & Director
- Mr. Tal RozenfeldChief Financial Officer
- Mr. Anthony GoonetillekeGroup President of Technology & Head of Strategy
- Mr. Matthew E. SmithSecretary & Head of Investor Relations · born 1972
- Idit Duvdevany AronsohnHead of Corporate Responsibility, Inclusion & Wellbeing
- Mr. Avishai SharlinGM & Division President · born 1967
- Mustafa OyumiHead of B2B Strategy
- Mr. Rajat RahejaDivision President of Amdocs Development Centre India LLP · born 1969